EP0998288 - COMPOSITIONS CONTAINING CAPSAICIN OR CAPSAICIN ANALOGUES AND A LOCAL ANESTHETIC [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 17.06.2005 Database last updated on 19.10.2024 | Most recent event Tooltip | 30.11.2012 | Lapse of the patent in a contracting state | published on 02.01.2013 [2013/01] | Applicant(s) | For all designated states Campbell, James N. 707 Hillstead Drive Lutherville, MD 21093 / US | For all designated states Pappagallo, Marco Apartment N-26-G, 401 East 34th Street New York, NY 10016 / US | For all designated states Meyer, Richard A. 10084 Shaker Drive Columbia, MD 21046 / US | [N/P] |
Former [2002/23] | For all designated states CAMPBELL, James, N. 707 Hillstead Drive Lutherville, MD 21093 / US | ||
For all designated states Pappagallo, Marco Apartment N-26-G, 401 East 34th Street New York, New York 10016 / US | |||
For all designated states Meyer, Richard A. 10084 Shaker Drive Columbia, MD 21046 / US | |||
Former [2000/19] | For all designated states CAMPBELL, James, N. 707 Hillstead Drive Lutherville, MD 21093 / US | ||
For all designated states Pappagallo, Marco Apartment 151, 2809 Boston Street Baltimore, MD 21224 / US | |||
For all designated states Meyer, Richard A. 10084 Shaker Drive Columbia, MD 21046 / US | Inventor(s) | 01 /
see applicant ... | [2000/19] | Representative(s) | Bassett, Richard Simon Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
Former [2000/19] | Bassett, Richard Simon Eric Potter Clarkson, Park View House, 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 98911614.0 | 12.03.1998 | [2000/19] | WO1998US04912 | Priority number, date | US19970040697P | 13.03.1997 Original published format: US 40697 P | [2000/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9840070 | Date: | 17.09.1998 | Language: | EN | [1998/37] | Type: | A1 Application with search report | No.: | EP0998288 | Date: | 10.05.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.09.1998 takes the place of the publication of the European patent application. | [2000/19] | Type: | B1 Patent specification | No.: | EP0998288 | Date: | 26.06.2002 | Language: | EN | [2002/26] | Type: | B2 New European patent specification | No.: | EP0998288 | Date: | 03.08.2005 | Language: | EN | [2005/31] | Search report(s) | International search report - published on: | EP | 17.09.1998 | Classification | IPC: | A61K31/47, A61K31/445, A61K31/245, A61K31/165, A61P29/00 | [2001/27] | CPC: |
A61K31/245 (EP,US);
A61K31/00 (EP,US);
A61K31/165 (EP,US);
A61K31/445 (EP,US);
A61K31/47 (EP,US);
A61P19/02 (EP);
A61P21/00 (EP);
A61P23/00 (EP);
A61P23/02 (EP);
| C-Set: |
A61K31/165, A61K2300/00 (EP,US);
A61K31/165, A61K31/165 (US,EP);
A61K31/245, A61K2300/00 (EP,US);
A61K31/245, A61K31/165 (US,EP);
A61K31/445, A61K2300/00 (EP,US);
A61K31/445, A61K31/165 (US,EP); |
Former IPC [2000/19] | A61K31/47, A61K31/445, A61K31/245, A61K31/165 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/19] | Title | German: | ZUSAMMENSETZUNG ENTHALTEND CAPSAICIN ODER SEINE ANALOGEN UND LOKALANÄSTHETIKA | [2000/19] | English: | COMPOSITIONS CONTAINING CAPSAICIN OR CAPSAICIN ANALOGUES AND A LOCAL ANESTHETIC | [2000/19] | French: | COMPOSITIONS CONTENANT DE LA CAPSAICINE OU DES ANALOGUES DE CAPSAICINE ET UN ANESTHESIQUE LOCAL | [2000/19] | Entry into regional phase | 13.10.1999 | National basic fee paid | 13.10.1999 | Designation fee(s) paid | 13.10.1999 | Examination fee paid | Examination procedure | 12.10.1998 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 13.10.1999 | Examination requested [2000/19] | 29.03.2001 | Despatch of a communication from the examining division (Time limit: M02) | 02.05.2001 | Reply to a communication from the examining division | 28.05.2001 | Despatch of communication of intention to grant (Approval: Yes) | 12.12.2001 | Communication of intention to grant the patent | 28.02.2002 | Fee for grant paid | 28.02.2002 | Fee for publishing/printing paid | Divisional application(s) | EP01204603.3 | EP01204692.6 / EP1201241 | Opposition(s) | Opponent(s) | 01
26.03.2003
ADMISSIBLE Grünenthal GmbH Zieglerstrasse 6 52078 Aachen / DE | [N/P] |
Former [2003/21] | |||
Opponent(s) | 01
26.03.2003
ADMISSIBLE Firma Grünenthal GmbH Zieglerstrasse 6 52078 Aachen / DE | 30.04.2003 | Invitation to proprietor to file observations on the notice of opposition | 07.11.2003 | Reply of patent proprietor to notice(s) of opposition | 12.11.2004 | Despatch of interlocutory decision in opposition | 22.11.2004 | Legal effect of interlocutory decision in opposition | 03.03.2005 | Despatch of communication that the patent will be maintained as amended | 03.06.2005 | Fee for printing new specification paid | Fees paid | Renewal fee | 27.03.2000 | Renewal fee patent year 03 | 27.03.2001 | Renewal fee patent year 04 | 04.03.2002 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US4997853 (BERNSTEIN JOEL E [US]) [X] 1-16 * column A; claim 1 *; | [X]US5008289 (BERNSTEIN JOEL E [US]) [X] 1-16 * claim 1 *; | [X]WO9640079 (UNIV EMORY [US]) [X] 1-16* page 22, lines 1-3 * | Opposition | US4313958 | US4424205 | US4812446 | US5290816 | - K.D. Davis et al. (1995), "Cutaneous injection of the capsaicin analogue, NE-21610, produces analgesia to heat but not to mechanical stimuli in man" PAIN, 61; S. 17-26 | - M. Lazzeri et al. (1996) "Intravesical Capsaicin for treatment of severe bladder Pain: A randomized Placebo Controlled Study" The Journal of Urology, 156; S. 947-952 | - R.M. Craft u. F. Porreca (1994) "Tetracaine attenuates irritancy without attenuating desensitization produced by intravesical resiniferatoxin in the rat" Pain, 57; S. 351-359 | - A.J. Winnig et al (1986) "Respiratory and cardiovascular effects of central and peripheral intravenous injections of capsaicin in man: evidence for pulmonary chemosensivity" Clinical Science, 71; S. 519-526 | - J. Wallengren u. R. Hakanson (1992) "Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin" British Journal of Dermatology, 126; S. 111-117 | - M. Dux et al. (1996) "Inhibition of the neurogenci inflammatory response by lidocaine in rat skin" Inflamm. Res., 45; pp. 10-13 | - J.B. Eppstein (1994), Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia" Oral Surg. Oral Med. Oral Pathol., 77; pp. 135-140 | - C.C. Toh et al. (1955) "The pharmacological actions of capsaicin and analogues", Brit. J. Pharmacol, 10; S. 176-182 | - K.D. Davis et al. (1995), "Cutaneous pretrreatment with the capsaicin analog NE-21610 prevents the pain to a burn and subsequent hyperalgesia" Pain, 62; S. 373-378 | - C.A. Maggi et al. (1990) "Similarities and differences in the action of resiniferatoxin and capsaicin on central and peripheral endings of primary sensory neurons" Neurosience, 37(2), S. 531-539 |